{"paper_id":"283ce150-5a63-4bd5-8f73-02a5f5d9aaad","body_text":"INTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 177 www.rsisinternational.org \n        \n   \nProgression of Endometriosis: Mechanisms of Implantation and \nExpansion of Ectopic Endometrial Tissue \nAugusto Cam Rojas1*, Vanessa Ma Lei2, Guillermo Moises Díaz Quiroz3, Essalud Angamos 4 \n1,2Universidad Peruana de Ciencias Aplicadas \n3,4Karelia Díaz Villanueva, Universidad Científica del Sur \n*Corresponding Author \nDOI: https://doi.org/10.51244/IJRSI.2026.13020016 \nReceived: 05 February 2026; Accepted: 11 February 2026; Published: 24 February 2026 \nABSTRACT  \nEndometriosis is a chronic gynecological disorder characterized by the implantation and growth of \nendometriallike tissue outside the uterine cavity, with a highly variable clinical course and complex underlying \nbiology. The objective of this review was to synthesize current mechanistic evidence explaining how \nendometriosis progresses from initial ectopic implantation to sustained lesion expansion and long -term \npersistence. A narrative integrative approach was employed to analyze experimental, translational,  and clinical \nstudies addressing implantation, immune modulation, endocrine dysregulation, angiogenesis, \nneuroangiogenesis, and microenvironmental remodeling. The reviewed evidence indicates that lesion \nestablishment is a selective process requiring coordi nated adhesion, invasion, and extracellular matrix \nremodeling, supported by permissive immune and stromal environments. Chronic inflammation and immune \ntolerance consistently emerge as foundational features, enabling ectopic tissue survival despite ongoing  \ninflammatory signaling. Endocrine alterations — particularly local estrogenic activity and progesterone \nresistance—interact with inflammatory pathways to reinforce proliferative and anti -apoptotic programs. \nAngiogenesis and neuroangiogenesis further contri bute to lesion expansion by providing metabolic, vascular, \nand neural support, while microenvironmental stressors such as hypoxia and oxidative stress promote long-term \nremodeling and persistence. Collectively, the findings support a systems -based model of  endometriosis \nprogression in which immune, endocrine, vascular, neural, and stromal mechanisms converge through \nreinforcing feedback loops. This integrative perspective advances the understanding of endometriosis as a \nprogressive and adaptive disease process and highlights the need for multidimensional research and therapeutic \nstrategies that address interacting biological domains rather than isolated pathways.  \nKeywords:  Endometriosis; Ectopic implantation; Immune dysregulation; Progesterone resistance; \nAngiogenesis and neuroangiogenesis  \nINTRODUCTION  \nEndometriosis is a chronic gynecological  disorder characterized by the presence of endometrial -like tissue \noutside the uterine cavity, most commonly affecting the pelvic peritoneum, ovaries, and surrounding structures. \nIt is estimated to affect approximately 10% of women of reproductive age worldwide, representing a significant \ncause of chronic pelvic pain, infertility, and reduced quality of life [1], [2]. Despite its high prevalence and \nclinical burden, the biological mechanisms underlying the implantation, survival, and progressive expansion o f \nectopic endometrial tissue remain incompletely understood. This persistent gap in knowledge continues to limit \nthe development of effective diagnostic tools and targeted therapeutic strategies.  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 178 www.rsisinternational.org \n        \n   \nThe progression of endometriosis is increasingly recognized as a dynamic and multifactorial process rather than \na static displacement of endometrial fragments. Classical theories, such as Sampson’s hypothesis of retrograde \nmenstruation, provide an initial framework for understanding the ectopic distribution of endometrial tissue [19]. \nHowever, retrograde menstruation occurs in the majority of menstruating women, while only a subset develops \nendometriosis, suggesting that additional biological mechanisms are  required for lesion establishment and \nprogression [3], [4]. Contemporary research therefore emphasizes the role of local immune dysregulation, \ninflammatory signaling, angiogenesis, neurogenesis, and aberrant hormonal responses in facilitating the \nimplantation and expansion of ectopic lesions [5]–[7].  \nFrom a pathophysiological perspective, implantation of ectopic endometrial tissue requires a permissive \nperitoneal environment that supports adhesion, invasion, and vascularization. Experimental and clinical studies \nhave demonstrated that endometriotic les ions exhibit enhanced expression of adhesion molecules, matrix \nmetalloproteinases, and pro -angiogenic factors, enabling them to attach to mesothelial surfaces and infiltrate \nsurrounding tissues [10] –[12]. Concurrently, alterations in immune surveillance —particularly involving \nmacrophages, natural killer cells, and cytokine networks —contribute to reduced clearance of ectopic cells and \nsustain a chronic inflammatory microenvironment [8], [9], [14]. These mechanisms not only promote lesion \nsurvival but also drive lesion growth and symptom persistence.  \nRecent advances have further highlighted the role of estrogen-dependent signaling pathways and local estrogen \nbiosynthesis in the progression of endometriosis. Ectopic lesions demonstrate increased aromatase activity and \naltered progesterone responsiveness , creating a hormonal milieu that favors proliferation, inflammation, and \nresistance to apoptosis [2], [15]. Additionally, emerging evidence suggests that neural infiltration and \nneuroangiogenesis are key contributors to both lesion expansion and pain generation, reinforcing the concept of \nendometriosis as a systemic and progressive disease rather than a localized gynecological condition [21], [22].  \nGiven these complexities, there is growing consensus that endometriosis progression cannot be adequately \nexplained by a single etiological theory. Instead, it reflects the interaction of genetic susceptibility, epigenetic \nmodifications, immune dysfunction, and environmental influences within a hormonally responsive tissue context \n[24], [25]. This multifaceted nature underscores the need for integrative research approaches that synthesize \nmolecular, cellular, and clinical evidence to better understand disease evolution.  \nIn this context, the present review aims to examine the mechanisms involved in the implantation and expansion \nof ectopic endometrial tissue, focusing on the biological processes that drive disease progression. Rather than \nproviding an exhaustive systematic analysis, this review adopts a narrative and integrative approach, drawing on \nkey experimental, translational, and clinical studies to contextualize current knowledge. The guiding research \nquestions address how ectopic endometrial cells establish themselv es within extrauterine environments and \nwhich molecular and cellular pathways sustain their long-term survival and growth.  \nThe design of this review aligns with these questions by synthesizing findings related to inflammation, immune \nmodulation, angiogenesis, extracellular matrix remodeling, and hormonal regulation. By integrating evidence \nfrom diverse research settings, inclu ding contributions from Latin American scientific communities, this work \nseeks to provide a coherent framework for understanding endometriosis progression. Such an approach not only \nsupports educational objectives but also highlights areas where further in vestigation is required to advance \ndiagnostic and therapeutic innovation.  \nMETHODOLOGY  \nThis manuscript was developed as a narrative integrative review focused on the biological progression of \nendometriosis, specifically the mechanisms that enable implantation, survival, and expansion of ectopic \nendometrial-like tissue. A narrative integrativ e design was selected to allow cross -disciplinary synthesis of \nmechanistic evidence spanning molecular biology, immunology, endocrinology, vascular biology, and \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 179 www.rsisinternational.org \n        \n   \nclinicaltranslational research—areas where heterogeneity in study models and outcomes frequently limits direct \nquantitative pooling. This approach is widely used when the objective is to map mechanistic pathways, identify \nconvergent evidence across experim ental systems, and propose a coherent framework to guide education and \nfuture research [3], [4], [5].  \nThe review prioritizes mechanistic interpretability over sheer volume of studies. In practical terms, this means \nemphasis was placed on articles that: (i) propose or test causal pathways relevant to ectopic lesion establishment \nand progression, (ii) provide reproducible experimental logic in human tissue, animal models, or in vitro systems, \nand/or (iii) demonstrate translational relevance through clinical phenotyping, biomarker work, or therapeutic \ntargeting of implicated pathways [2], [3], [4], [22].  \nConceptual framework and guiding questions A conceptual framework was defined before literature retrieval to \nmaintain internal coherence and reduce thematic drift. The framework operationalized endometriosis progression \nas a sequence of interdependent biological phases:  \n1. Tissue delivery and survival: arrival of endometrial cells/tissue fragments to ectopic sites and early \nsurvival under oxidative/inflammatory stress.  \n2. Adhesion and invasion: attachment to mesothelium and extracellular matrix remodeling enabling \ninfiltration.  \n3. Immune tolerance and chronic inflammation: altered immune surveillance, macrophage polarization, \ncytokine persistence, and impaired clearance.  \n4. Angiogenesis and neuroangiogenesis: vascular and neural remodeling sustaining growth and pain \npathways.  \n5. Hormonal support and progesterone resistance: local estrogen synthesis and altered progesterone \nsignaling favoring proliferation and reduced apoptosis.  \n6. Lesion maintenance, remodeling, and recurrence: long -term survival, fibrotic remodeling, and \npersistence despite therapy.  \nFrom this framework, the review was guided by the following research questions:  \n● RQ1: Which molecular and cellular mechanisms enable ectopic endometrial-like tissue to adhere, invade, \nand establish stable lesions?  \n● RQ2: How do immune dysregulation and chronic inflammation interact with hormonal signaling to \npromote lesion persistence and expansion?  \n● RQ3: What is the mechanistic role of angiogenesis and neuroangiogenesis in lesion progression and \nsymptom generation?  \n● RQ4: Which pathways appear most consistently across experimental systems and are most plausible as \ntherapeutic targets?  \nThese questions were intentionally structured to link mechanistic evidence to interpretable biological stages of \nprogression, reflecting the integrative emphasis in contemporary endometriosis research [3], [4], [7], [22].  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 180 www.rsisinternational.org \n        \n   \nLiterature search strategy  \nA comprehensive search strategy was implemented to capture high-quality evidence relevant to implantation and \nprogression of ectopic endometrial tissue. Searches were performed across major biomedical databases and \ncomplementary sources, emphasizing peer-reviewed literature.  \nDatabases and platforms included:  \n● PubMed/MEDLINE  \n● Scopus  \n● Web of Science Core Collection  \n● Embase (where institutional access was available)  \n● Cochrane Library (for high-level summaries and clinically anchored perspectives)  \nTo ensure that mechanistic work not indexed uniformly across platforms was captured, forward and backward \ncitation chaining was performed for foundational and high -impact review articles and landmark mechanistic \npapers [2] –[5]. Additionally, targeted hand -searching was applied to key journals frequently publishing \nendometriosis mechanistic studies (e.g., Human Reproduction Update , Fertility and Sterility , Reproductive \nSciences, Nature Reviews Endocrinology) [3]–[6], [22].  \nSearch terms and query construction  \nSearch queries were built using controlled vocabulary (when available) and free -text keywords to reflect the \nconceptual framework. Terms were combined using Boolean operators and adapted per database syntax.  \nCore concept block (disease):  \n● “endometriosis” OR “endometriotic” OR “ectopic endometrium” OR “endometrial-like tissue”  \nMechanism block (implantation and expansion):  \n● “implantation” OR “adhesion” OR “invasion” OR “mesothelium”  \n● “extracellular matrix” OR “matrix metalloproteinase” OR “MMP”  \n● “angiogenesis” OR “VEGF” OR “vascularization”  \n● “neurogenesis” OR “nerve growth factor” OR “neuroangiogenesis”  \n● “immune dysregulation” OR “macrophage” OR “natural killer cell” OR “cytokine” OR “inflammation”  \n● “estrogen” OR “aromatase” OR “progesterone resistance” OR “steroid signaling”  \n● “fibrosis” OR “remodeling” OR “recurrence”  \nStudy-model block (optional refiners):  \n● “peritoneal fluid” OR “stromal cell” OR “organoid” OR “animal model” OR “in vitro” OR “translational”  \nSearches were iteratively refined to balance sensitivity and specificity. When searches retrieved excessive \nunrelated gynecologic pain literature without mechanistic focus, additional refiners (e.g., “angiogenesis,” \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 181 www.rsisinternational.org \n        \n   \n“MMP,” “macrophage”) were applied. Conversely, when the yield was low for specific subdomains (e.g., \nneuroangiogenesis), broader terms were used and then screened manually for relevance [21], [22].  \nEligibility criteria  \nEligibility criteria were pre-specified to ensure consistency and to prioritize mechanistic relevance.  \nInclusion criteria:  \n1. Peer-reviewed original research, systematic reviews, or authoritative narrative reviews addressing one or \nmore mechanisms of:  \n○ ectopic implantation, adhesion, invasion  \n○ immune modulation/inflammation  \n○ angiogenesis/neuroangiogenesis  \n○ hormonal regulation (local estrogen biosynthesis, progesterone resistance)  \n○ extracellular matrix remodeling/fibrosis  \n2. Human clinical/translational studies (tissue -based, biomarker, peritoneal fluid, imaging correlated with \nphenotype) and/or robust experimental studies (in vitro, ex vivo, animal models) with clear mechanistic \nendpoints.  \n3. Studies with sufficient methodological detail to support interpretability (defined outcomes, experimental \nlogic, and reproducible approach).  \n4. Priority to literature published in the last ~15 years to reflect modern molecular and systems -level \ninsights, while retaining seminal foundational works essential for conceptual continuity (e.g., the \nretrograde menstruation hypothesis) [19].  \nExclusion criteria:  \n1. Case reports/series without mechanistic content or without link to lesion progression biology.  \n2. Studies focused exclusively on symptom management without mechanistic discussion (unless they \nprovided mechanistic biomarkers or pathway-linked effects).  \n3. Non-peer-reviewed sources lacking transparent methodological standards.  \n4. Articles where the primary outcome was unrelated to implantation/progression (e.g., purely \nepidemiologic reports without biological inference).  \nThis structure ensured that the review remained anchored to the manuscript’s objective: explaining how lesions \nestablish and grow, not merely describing disease prevalence or therapeutic outcomes [3], [4], [22].  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 182 www.rsisinternational.org \n        \n   \nStudy selection and screening process  \nStudy selection proceeded in staged screening:  \n1. Deduplication: Records retrieved from multiple databases were consolidated and duplicates removed.  \n2. Title/abstract screening: Two reviewers independently screened for relevance to \nimplantation/progression mechanisms, using the conceptual framework as the screening guide.  \n3. Full-text assessment: Articles passing initial screening were evaluated in full text for eligibility, \nmechanistic relevance, and methodological clarity.  \n4. Consensus resolution: Discrepancies were resolved through discussion, prioritizing mechanistic \ncentrality and evidentiary strength. When disagreement persisted, a third senior reviewer adjudicated.  \nThis multi -stage process was used to reduce selection bias and improve internal consistency of included \nevidence—particularly important in endometriosis, where heterogeneous models and terminology can obscure \nmechanistic comparability [4], [5], [7].  \nData extraction and organization  \nA structured extraction template was used to standardize information across study types. Extracted elements \nincluded:  \n● Study identification: authors, year, setting, design  \n● Population/model: human tissue source and phenotype (if applicable), animal model species/strain, in \nvitro cell type or organoid system  \n● Lesion type or compartment: peritoneal, ovarian endometrioma, deep infiltrating endometriosis (when \nspecified)  \n● Mechanistic domain: immune/inflammation, angiogenesis, ECM remodeling, hormonal signaling, \nneurobiology  \n● Key markers/pathways: cytokines, immune cell profiles, VEGF/angiogenic mediators, MMPs, \naromatase/progesterone signaling pathways, neurotrophic factors  \n● Outcome logic: endpoints reflecting implantation (adhesion/invasion), expansion  \n(proliferation/vascularization), persistence (apoptosis resistance), or remodeling (fibrosis)  \n● Primary findings and limitations: effect direction, strength, model constraints, confounders, replicability \nconsiderations  \n● Translational linkage: clinical phenotype alignment, therapeutic implications, biomarker relevance  \nExtracted evidence was then mapped back onto the staged progression framework, enabling synthesis that tracks \nthe evolution from early implantation steps to advanced lesion maintenance and remodeling [3], [4], [10]–[12].  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 183 www.rsisinternational.org \n        \n   \nQuality appraisal and evidence weighting  \nGiven the inclusion of diverse study designs, formal quantitative risk-of-bias scoring was not applied uniformly. \nInstead, evidence weighting was performed using design-sensitive criteria:  \n● Human mechanistic/translational studies: preference was given to studies with clear phenotyping, \nwelldefined tissue origin, appropriate controls, and validated assays.  \n● Experimental studies: priority was assigned to designs demonstrating reproducible mechanistic causality \n(e.g., pathway inhibition/activation, functional assays of adhesion/invasion, angiogenesis readouts, \nimmune-cell functional profiling).  \n● Review-level evidence: high -impact, widely cited reviews were used primarily for conceptual framing \nand triangulation, not as sole support for mechanistic claims [3]–[5], [22].  \nAcross domains, findings were interpreted with explicit attention to model limitations —especially the known \ndifferences between peritoneal lesions, ovarian endometriomas, and deep infiltrating endometriosis regarding \nfibrosis, innervation, and immune signatures [3], [7], [22].  \nNarrative synthesis strategy  \nSynthesis was conducted using a convergence-of-evidence approach:  \n1. Within-domain synthesis: immune mechanisms, ECM remodeling, angiogenesis, and hormonal signaling \nwere each summarized independently to identify consistent pathways and points of disagreement.  \n2. Cross-domain integration: mechanistic interactions were then integrated (e.g., inflammatory cytokines \nupregulating angiogenic signals; estrogen amplifying inflammatory networks; macrophage -mediated \nremodeling facilitating invasion).  \n3. Stage-based progression narrative: results were arranged according to progression phases (adhesion → \ninvasion → vascularization → persistence/remodeling), allowing a biologically coherent explanation of \nlesion evolution.  \n4. Translational interpretation: mechanistic pathways were linked to clinical implications (pain generation, \ninfertility, recurrence risk, therapeutic targeting), maintaining careful language that reflects evidence \nstrength [4], [21], [22].  \nThis method supports teaching objectives by presenting a structured pathophysiologic storyline, while remaining \nrigorous in differentiating well-established mechanisms from emerging hypotheses.  \nInternational perspective and regional representation  \nTo reflect an international scope—particularly with relevance to Mexico, Colombia, and Ecuador —the review \nincluded targeted screening for:  \n● Latin American clinical/translational contributions in recognized indexed journals,  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 184 www.rsisinternational.org \n        \n   \n● regional epidemiologic or phenotyping work that links to biological mechanisms, and  \n● multi-country collaborations that address diagnostic delays, clinical heterogeneity, and research needs.  \nRegional representation was treated as an added interpretive layer, emphasizing how diverse healthcare contexts \ninfluence the visibility and characterization of disease progression, without compromising the biomedical core \nof the review. This approach aligns with calls for broader global participation in endometriosis research and for \nframeworks that remain valid across populations and settings [22].  \nEthical considerations  \nThis work is based exclusively on the analysis and synthesis of previously published scientific literature. No new \ndata were collected from human participants, no interventions were performed, and no identifiable patient \ninformation was accessed. According ly, formal ethics committee approval and informed consent were not \nrequired for this type of scholarly review.  \nRESULTS  \nThis section summarizes the most relevant findings identified across the body of evidence included in the review, \norganized according to the biological sequence that underpins lesion implantation and subsequent expansion of \nectopic endometrial-like tissue. The results are presented as synthesized patterns across study types (human tissue \nand fluid studies, translational cohorts, and mechanistic experimental models), emphasizing consistency, \ndirectionality, and recurrence of findings rather than isolated obs ervations. In line with standard reporting for \nintegrative reviews, results are communicated using descriptive aggregation (e.g., “frequently reported,” \n“commonly elevated,” “consistently associated”) and —when supported by multiple studies —summarized as \ncomparative trends between eutopic endometrium, ectopic lesions, and relevant peritoneal microenvironment \ncompartments. Individual -level values and granular participant data are not reported, as the purpose of this \nsection is to present consolidated evidence that will later support interpretation and implications.  \nThe results are structured into four mechanistic domains that repeatedly emerge as central to disease progression: \n(1) early implantation biology (adhesion, invasion, and survival under stress), (2) immune modulation and \nchronic inflammation, (3) angiogenesis and neuroangiogenesis supporting lesion maintenance and growth, and \n(4) endocrine-metabolic support, including local estrogenic activity and progesterone resistance. Within each \ndomain, the review highlights the most reproducible molecular and cellular  signals reported in the literature — \nsuch as extracellular matrix remodeling mediators, macrophage- and cytokine-centered inflammatory networks, \npro-angiogenic signaling, and steroid pathway alterations —alongside how these signals align with observed \nlesion phenotypes and lesion persistence. Importantly, while these results are arranged in a progression-oriented \nnarrative, causal interpretation and clinical implications are intentionally deferred to the Discussion section, \nwhere competing explanations, model limitations, and translational relevance are addressed explicitly.  \n \n \n \n \n \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 185 www.rsisinternational.org \n        \n   \nFigure 1. Evidence map of included studies by study design/model type and mechanistic domain (implantation \nand progression biology).  \n  \nFigure 1 summarizes how the included evidence is distributed across mechanistic domains central to the \nprogression of endometriosis —adhesion/invasion, immune –inflammatory modulation, \nangiogenesis/neuroangiogenesis, hormonal/progesterone resistance, and fib rosis/remodeling—and across the \nprincipal study-model categories that dominate mechanistic research (human clinicaltranslational material, in \nvitro systems, animal models, and omics/systems biology). This mapping is presented to document the empirical \nbase underpinning subsequent synthesis, and to clarify how different model types cluster around particular \nbiological questions. Consistent with contemporary frameworks, progression is approached as an interconnected \nsequence of events where early implantation  biology (adhesion/invasion) is reinforced by persistent \ninflammation and immune tolerance, followed by vascular and neural remodeling and, in many phenotypes, \nprogressive fibrotic change and architectural remodeling [3], [4], [22].  \nA first pattern evident in Figure 1 is the dominant representation of human clinical -translational studies across \nall domains. This reflects the field’s reliance on human lesion tissue, eutopic endometrium comparisons, and \nperitoneal fluid profiling to identify molecular signatures associated with lesion establishment and persistence. \nThe concentration is particularly marked within immune & inflammation, which aligns with the longstanding \n\n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 186 www.rsisinternational.org \n        \n   \nrecognition that endometriosis lesions exist within a sustained inflammatory milieu and that immune -cell \ndysregulation (especially macrophage -centered networks, altered cytotoxic surveillance, and cytokine \npersistence) is repeatedly measurable in human samples [8], [9], [14]. This is consistent with the broad view that \ninflammation is not merely a correlate of symptoms, but a recurrent biological context in which lesion survival \nand growth are supported [4], [7].  \nSecond, the figure shows substantial contribution from in vitro primary -cell and co-culture systems, especially \nwithin adhesion/invasion and immune–inflammatory domains. This distribution mirrors the mechanistic need to \ninterrogate cell –cell and cell –matrix interactions directly: adhesion to mesothelial surfaces, epithelial – \nmesenchymal–like transitions, extracellular matrix degradation, and invasion -related pathways are often \nexamined using controlled assays that quantify adhesion, migration, proteolytic activity, and matrix remodeling. \nSuch methods are commonly used to characterize the functional roles of extracellular matrix mediators and \nmatrix metalloproteinases (MMPs), which are repeatedly linked to lesion invasiveness and the ability of ectopic \ntissue to establish itself at extrauterine sites [11], [12]. The prominence of in vitro evidence in these domains \ntherefore reflects where experimental control is most essential: testing invasion biology, rather than simply \ndescribing it [4], [10]–[12].  \nThird, Figure 1 indicates that animal models contribute meaningfully, with a particularly visible presence in \nangiogenesis/neuroangiogenesis  and  adhesion/invasion,  while  remaining  less  represented in \nhormonal/progesterone resistance relative to human-based work. This pattern is consistent with how preclinical \nmodels are typically used in the field: they are especially valuable for evaluating the temporal evolution of \nlesions, vascularization dynamics, and the effects of perturbing angiogenic pathways in vivo. The observed \nclustering around vascular domains aligns with the established importance of angiogenic signaling—frequently \ncentered on VEGF -related pathways and microvascular remodeling —as a sustaining mechanism for lesion \ngrowth and maintenance [1 0], [12]. Likewise, the growing recognition of neuroangiogenesis and lesion \ninnervation as contributors to lesion persistence and pain biology has promoted the use of models that permit \nevaluation of neurovascular co-development in a way that is not feasib le in human observational designs alone \n[21], [22].  \nFourth, the omics/systems biology category appears comparatively concentrated in hormonal/progesterone \nresistance, a distribution that aligns with the complexity of steroid -related signaling and the frequent need to \nintegrate transcriptomic, epigenetic, or  pathway-level data to characterize progesterone resistance and local \nestrogen biosynthesis. The presence of omics evidence in this domain is consistent with the broader literature \ndescribing altered steroid receptor signaling, inflammatory–hormonal cross-talk, and lesion-specific biosynthetic \ncapacity (e.g., aromatase-related local estrogen activity) as recurring components of disease progression [2], [3], \n[15]. Importantly, while hormonal mechanisms are often clinically anchored, the mechanistic descripti ons \nfrequently depend on multi-layered data structures that omics approaches are well-positioned to capture [3], [7].  \nFinally, Figure 1 shows that fibrosis/remodeling has a comparatively smaller evidence footprint across model \ntypes, relative to immune/inflammatory and implantation -related domains. This distribution is noteworthy \nbecause fibrotic remodeling is increasingly recognized as a defining feature in specific endometriosis phenotypes \nand may influence lesion stiffness, invasiveness, and persistence. However, fibrosis is methodologically \nchallenging to standardize across studies, partly because remodeling is strongl y influenced by lesion subtype, \nanatomical compartment, and disease duration. The smaller aggregate footprint in this domain is therefore \ncompatible with the idea that fibrosis/remodeling is important but less uniformly captured across the mechanistic \nliterature compared with inflammation and angiogenesis [3], [7], [22].  \n \n \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 187 www.rsisinternational.org \n        \n   \nFigure 2. Stage-based schematic of implantation → invasion → vascularization → maintenance.  \n  \nFigure 2 organizes the consolidated evidence into a stage -based progression sequence that begins with tissue \ndelivery and early survival, proceeds through adhesion to mesothelium and invasion with extracellular matrix \n(ECM) remodeling, and culminates in an giogenesis/neuroangiogenesis followed by maintenance, remodeling, \nand recurrence risk. The diagram is not intended to imply a single linear cause; rather, it reflects how multiple \nlines of evidence repeatedly converge on a temporal logic: for ectopic endometrial-like tissue to persist, it must \nsurvive early stressors, attach to host surfaces, invade and remodel its local environment, acquire vascular \nsupport, and then stabilize through hormonal and inflammatory reinforcement that sustains lesion viability over \ntime [3], [4], [22].  \n1) Tissue delivery and early survival.  \nThe initial stage captures the widely cited concept that endometrial tissue fragments can reach ectopic sites \n(classically via retrograde menstruation), but that arrival alone is insufficient to explain disease development and \nprogression [19], [3]. The “early survival” component emphasizes that ectopic fragments face immediate hostile \nconditions—hypoxia, oxidative stress, immune surveillance, and mechanical clearance —yet lesions that \nestablish demonstrate functional adaptations consistent with stress toler ance and immune escape. This stage \naligns with the broader observation that endometriosis is characterized by selective lesion establishment despite \ncommon retrograde menstruation, indicating the necessity of permissive host–tissue interactions [3], [4], [24].  \n2) Adhesion to mesothelium.  \nThe second stage reflects a recurring mechanistic theme: ectopic cells must adhere to peritoneal/mesothelial \nsurfaces to transition from transient contamination to stable implantation. Across human and experimental \nstudies, adhesion-related behavior is often linked to altered expression of adhesion molecules and changes in the \nperitoneal environment that facilitate cell attachment and retention. While specific molecules vary by study, the \nconsistent result-level pattern is that adhesion processes are measur able and functionally relevant in models \nexamining implantation steps [4], [12]. In this schematic, adhesion serves as a gatekeeping step that precedes \ninvasion; without stable attachment, downstream remodeling and vascularization cannot proceed.  \n\n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 188 www.rsisinternational.org \n        \n   \n3) Invasion and ECM remodeling.  \nThe third stage consolidates evidence showing that lesion establishment depends on ECM degradation and \nremodeling, enabling ectopic tissue to penetrate superficial layers and secure a niche. The representation of \n“Invasion & ECM remodeling” is supported by  the extensive literature on matrix metalloproteinases (MMPs) \nand related proteolytic systems repeatedly associated with invasive behavior and lesion architecture. Mechanistic \nstudies frequently use functional assays (migration/invasion, protease activity, matrix interactions) to show that \nremodeling is not merely descriptive but functionally tied to lesion development [11], [12]. Importantly, this \nstage also foreshadows later fibrosis/remodeling: the same ECM dynamics that enable invasion can, in longer \ntimeframes and in specific phenotypes, contribute to chronic remodeling and fibrotic change [3], [7].  \n4) Angiogenesis and neuroangiogenesis.  \nThe fourth stage highlights that lesions require vascular support to persist and expand. The consistent pattern \nacross domains is that endometriotic lesions are associated with a pro -angiogenic environment and vascular \nremodeling. Angiogenic mediators —including VEGF -centered signaling in many studies —are repeatedly \ndiscussed as critical for sustaining lesion growth and metabolic support [10], [12]. The addition of \nneuroangiogenesis reflects a growing body of evidence associating lesion progression with neur al infiltration \nand neurovascular co-development, which is also relevant to the biological substrate of pain in endometriosis. \nWhile the implications for symptoms are reserved for Discussion, the results -level synthesis supports \nneurovascular remodeling as a recurrent mechanistic element in lesion persistence frameworks [21], [22].  \n5) Maintenance, remodeling, and recurrence risk.  \nThe final stage represents the stabilized lesion state: lesions that have secured adhesion, invasive niche formation, \nand vascular/neural support may persist through cycles of inflammation and endocrine signaling. The label \n“maintenance, remodeling & recurrence risk” is used here as a results -structuring concept: many studies report \npersistence-related features such as resistance to apoptosis, altered hormone responsiveness, and chronic \ninflammatory signaling that promotes continued tissue viability [2], [3 ], [4]. This stage also accommodates \nevidence that some lesion phenotypes demonstrate long-term tissue remodeling (including fibrotic components) \nand a tendency toward persistence despite treatment —an observation repeatedly raised in broader reviews of \ndisease course and management [3], [22].  \nReinforcing loops: inflammation–immune tolerance and endocrine resistance.  \nA key feature of Figure 2 is the explicit depiction of two interacting reinforcing modules:  \n● Immune  tolerance  &  chronic  inflammation  →  invasion/maintenance  support.  \nEvidence repeatedly indicates that peritoneal and lesion microenvironments in endometriosis \ndemonstrate sustained inflammatory signaling and immune -cell alterations that reduce effective \nclearance of ectopic tissue. Macrophage activation patterns, cytokine persistence, and reduced cytotoxic \nsurveillance are frequently described as creating a permissive environment that supports \nadhesion/invasion and long-term persistence [8], [9], [14]. In the diagram, this module is linked upward \ninto the invasion stage to  reflect the recurrent association between inflammatory signaling and \nremodeling/invasive behavior.  \n● Local estrogenic activity & progesterone resistance → growth support and persistence. The endocrine \nreinforcement module reflects well-described patterns of altered steroid signaling in lesions, including local \nestrogenic activity and reduced progesterone responsiveness (“progesterone resistance”), which together \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 189 www.rsisinternational.org \n        \n   \npromote proliferative and inflammatory programs that stabilize lesion survival [2], [3], [15]. The reciprocal \narrows between the endocrine and inflammatory modules represent the repeatedly reported cross -talk \nwhereby estrogenic signaling can amplify inflammatory networks, and inflammatory mediators can in turn \ninfluence local steroid metabolism and receptor signaling [3], [4], [15].  \nOxidative stress & immune evasion as an early amplifier.  \nThe schematic places oxidative stress and immune evasion beneath the earliest stage to reflect the concept that \nearly lesion survival is shaped by stress biology and host defense interactions. This is consistent with the broader \nmechanistic framing that le sion establishment depends on early survival advantages under hostile conditions, \nwhich then allow subsequent adhesion and invasion events to proceed [3], [4], [24].  \nFigure 3. Summary heatmap of frequently reported inflammatory mediators and immune -cell shifts across \ncompartments   \n  \nFigure 3 consolidates recurrent findings across the included literature by displaying directional trends (↑ \nincreased, ↓ decreased, ↔ variable/mixed) for selected inflammatory mediators and immune features across \nthree commonly studied compartments: ectopic lesions, eutopic endometrium in affected individuals, and the \nperitoneal fluid/immune milieu. The purpose of this figure is to provide a structured view of what is repeatedly \nreported in mechanistic and translational studies when comparing the inflammato ry and immune landscape of \nendometriosis-associated tissues and environments. The heatmap does not represent individual patient values or \n\n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 190 www.rsisinternational.org \n        \n   \nany single dataset; rather, it expresses aggregate directionality consistently described across multiple study \ndesigns, enabling subsequent sections to reference patterns with clarity while deferring mechanistic implications \nto Discussion.  \nA central pattern evident in Figure 3 is the broad and coherent upward shift of canonical inflammatory \nmediators—including IL -6, TNF-α, IL-1β, and IL -8/CXCL8—across compartments, with particularly strong \ndirectionality in ectopic lesions and peritoneal imm une milieu. This aligns with the widely described \ncharacterization of endometriosis as a condition marked by persistent local inflammation, where lesions and \nsurrounding environments show elevated pro-inflammatory signaling and chemotactic activity that ca n support \ncellular recruitment and lesion persistence. Within the included evidence base, these mediators frequently appear \nin lesion tissue profiling and peritoneal fluid analyses, forming a reproducible inflammatory signature used to \nanchor many mechanistic models of disease progression [4], [8], [9], [14], [22].  \nThe figure also highlights a consistent increase in MCP -1/CCL2, a chemokine repeatedly linked to \nmonocyte/macrophage recruitment and immune -cell enrichment in the peritoneal environment. Directionality \nfor MCP-1 is shown as increased across compartments, with a strong signal particularly in the peritoneal milieu. \nThis presentation reflects the repeated reporting of heightened chemotactic gradients that favor innate immune \ncell accumulation in endometriosis -associated peritoneal fluid and lesion surroundings , reinforcing the robust \nrepresentation of macrophage-centered biology in mechanistic accounts of lesion establishment and maintenance \n[8], [9], [14].  \nAnother prominent feature is the upward trend for COX -2/PGE2 axis activity, represented here as increased \nacross compartments. COX -2-related inflammatory pathways are frequently included in mechanistic \ndescriptions because they are measurable in lesion tis sue and are often discussed as part of sustained \ninflammatory networks within endometriosis lesions and eutopic tissue in affected individuals. The figure’s \ndirectional summary reflects how COX-2/PGE2 pathway markers recur across studies addressing inflammatory \nreinforcement and local microenvironment changes [4], [3], [22].  \nThe heatmap further displays an increase in TGF -β, shown as elevated across compartments with moderate -\ntostrong directionality. TGF-β is frequently positioned at the interface of inflammation and tissue remodeling, \nand its repeated appearance across the li terature is consistent with the broader concept that endometriosis \nprogression involves not only inflammatory signaling but also remodeling programs that shape lesion \narchitecture. While the implications for fibrosis and remodeling are not discussed here, the result-level pattern \nsupports TGF-β as a recurrent feature in lesion-associated environments and tissue compartments [3], [7], [22].  \nImportantly, Figure 3 introduces a distinctly different directional trend for NK cell cytotoxicity, which is \nsummarized as decreased (↓) across compartments. This feature is included because multiple mechanistic and \nimmunobiology-focused studies describe r educed cytotoxic clearance capacity or altered NK cell function in \nendometriosis-associated immune settings. In the context of lesion establishment, diminished cytotoxic \nsurveillance is commonly reported as a reproducible immune feature that coexists with heightened inflammatory \nsignaling—an apparent paradox that underscores the immune dysregulation narrative frequently emphasized in \nauthoritative reviews and immunobiology -focused studies [8], [9], [14]. The figure captures this pattern \ndescriptively: inflammation is elevated, while a key cytotoxic effector function is commonly reported as reduced.  \nIn parallel, the figure summarizes a shift labeled “Treg / Th17 skew” as increased (↑), reflecting that multiple \nstudies report altered adaptive immune balance and regulatory/inflammatory T-cell signatures in endometriosis. \nThe directionality is presented as increased across compartments, with a less intense signal in eutopic \nendometrium than in lesions or peritoneal milieu, which matches how compartmental variability is frequently \ndescribed in immunologic profiling. This summary is intended to represent a recurring observation of immune \npolarization trends rather than asserting uniformity across all phenotypes, lesion subtypes, or disease stages [14], \n[22].  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 191 www.rsisinternational.org \n        \n   \nFinally, Figure 3 displays a strong upward trend in M2-like macrophage polarization, again most pronounced in \nlesions and peritoneal milieu. This reflects the frequent reporting of macrophage enrichment and polarization \npatterns that align with chronic inf lammatory persistence and tissue remodeling contexts. Within the results \nframing, the key point is that macrophage-related signals are repeatedly measurable and directionally consistent \nin lesion -associated compartments, which is one reason immune –inflammatory mechanisms dominate \nmechanistic models of endometriosis progression [8], [9], [14], [3], [4].  \nFigure 4. Comparative trend plot of angiogenesis-related signals across compartments  \n  \nFigure 4 summarizes directional patterns reported across the included evidence for angiogenesis-related features, \ndisplayed as normalized trend magnitudes across three commonly interrogated biological compartments: ectopic \nlesions, eutopic endometrium in a ffected individuals, and the peritoneal fluid/immune milieu. The figure is \nintended to capture a central result -level observation repeatedly emphasized in mechanistic and translational \nresearch: that endometriosis progression is supported by a pro-angiogenic tissue state, most prominently within \nlesions, with measurable pro-angiogenic signaling also present in the surrounding peritoneal environment. This \nrepresentation aligns with the widespread characterization of vascular remodeling as a sustaining component of \nlesion maintenance and expansion, rather than an incidental correlate [10], [12], [22].  \nA clear feature in Figure 4 is the comparatively higher trend magnitude for VEGF -related signals in ectopic \nlesions, with a secondary elevation in the peritoneal immune milieu. This pattern reflects the consistent reporting \nof VEGF-centered pro-angiogenic activity and microvascular remodeling signals in lesion tissue, coupled with \n\n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 192 www.rsisinternational.org \n        \n   \nsoluble or immune -associated angiogenic mediators detectable in peritoneal fluid. In many mechanistic \ndescriptions, VEGF-related signaling is one of the most recurrent vascular findings in endometriosis, supporting \nthe view that lesions actively participate in generating or sustaining a vascular niche that facilitates survival and \ngrowth [10], [12]. Importantly, the figure’s pattern is compartmental: lesion -local angiogenic activity appears \nstrongest, while peritoneal signals remain elevated but typically less intense than within lesion tissue itself—an \nobservation frequently consistent with “source -and-field” models where lesions act as focal drivers within a \npermissive inflammatory peritoneal environment [4], [12].  \nThe trend for the angiopoietin (ANGPT) axis follows a similar compartmental shape, with the highest magnitude \nagain localized to ectopic lesions and an intermediate magnitude in the peritoneal milieu. The inclusion of the \nANGPT axis reflects that angiogene sis in endometriosis is not described solely as VEGF -dependent; rather, \nvascular maturation and remodeling involve multiple signaling systems that regulate endothelial stability, vessel \nsprouting, and remodeling. Across the literature, angiopoietin -related pathways are frequently discussed \nalongside VEGF to describe the balance between sprouting angiogenesis and vascular maturation—mechanisms \nrelevant to sustaining lesion viability over time [12], [29]. In results terms, the pattern in Figure 4 captures tha t \nnon-VEGF angiogenic mediators also trend upward in lesion-associated compartments.  \nA third signal shown in Figure 4 is microvessel density (MVD proxy), which is presented with the strongest \nmagnitude in ectopic lesions. This is consistent with histologic and immunohistochemical approaches that report \nincreased vascularity or microvessel -related indices within lesions compared with eutopic tissue or control \nenvironments. Although methodological definitions vary (e.g., marker selection, counting strategies, lesion \nsubtype), MVD-related reporting remains a common translational anchor because  it provides a tangible tissue \ncorrelate of the pro -angiogenic molecular signals described in lesion biology [12], [29]. The figure therefore \nintegrates two complementary result -level lines: molecular pro -angiogenic signals (e.g., VEGF -related) and \ntissue vascularization proxies (MVD), both of which tend to align directionally toward increased angiogenic \nactivity in lesions.  \nThe fourth feature, endothelial activation markers, demonstrates a pattern of lesion -high and \nperitonealintermediate magnitude. This is included to reflect that lesion-associated vascular remodeling involves \nnot only the presence of vessels, but also endot helial activation states and endothelial –immune interactions \nwithin inflammatory microenvironments. In many mechanistic accounts, the peritoneal milieu in endometriosis \nis described as rich in inflammatory mediators that can modulate endothelial function, thereby linking immune \nand vascular domains without requiring the figure to interpret causality. The results -level message is that \nendothelial activation correlates are repeatedly detectable and tend to be most prominent in the lesion \ncompartment [4], [10], [12].  \nAcross all four vascular features, Figure 4 shows a shared compartmental profile: ectopic lesions consistently \npresent the strongest pro -angiogenic trend, eutopic endometrium in affected individuals shows intermediate or \nlower magnitude, and peritoneal flu id/immune milieu often demonstrates a meaningful elevation that sits \nbetween the two. This pattern is compatible with the recurrent observation that endometriosis is driven by both \nlesion-intrinsic biology and a supportive local environment. In results ter ms, the figure also underscores that \neutopic tissue from affected individuals can demonstrate altered signaling compared with typical baseline \nphysiology, which is frequently referenced in discussions of systemic or endometrium -wide predisposition; \nhowever, the implications of that observation remain outside this section and will be addressed later [3], [4], \n[22].  \nFigure 5. Matrix remodeling and invasion signature summary across compartments   \nFigure 5 synthesizes the evidence related to extracellular matrix (ECM) remodeling and invasion biology, \nsummarizing directional trends for key invasion -associated mediators and functional signatures across three \nrelevant contexts: ectopic lesions, eutopic  endometrium in affected individuals, and the peritoneal \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 193 www.rsisinternational.org \n        \n   \ninterface/mesothelium context (i.e., the tissue boundary where adhesion and invasion are commonly modeled \nand evaluated). This figure is included because invasion and remodeling constitute a crucial bridge between early \nimplantation and later lesion stabilization: after ectopic tissue is delivered and adheres, it must modify its local \nmicroenvironment to persist, expand, and interact with host tissue structures [4], [11], [12].  \nA dominant pattern in Figure 5 is the consistently higher trend magnitude of MMP -2 and MMP-9 signatures in \nectopic lesions, with intermediate elevations in the peritoneal interface context and more modest elevations in \neutopic tissue. The prominence of MMP -2 and MMP -9 reflects the repeatedly reported association between \nendometriosis progression and increased proteolytic capacity that supports tissue invasion. Mechanistic studies \nfrequently focus on these enzymes because they are directly linked to the degr adation of ECM components, \nfacilitation of cellular migration, and remodeling of tissue architecture that enables lesion establishment. Across \nthe included literature, MMP -related findings appear in both observational tissue profiling and functional \nexperiments where ECM interactions and invasion are measured directly, supporting the inclusion of MMPs as \ncentral, repeatedly reported components of invasion signatures [11], [12].  \nThe figure also summarizes disruption in TIMPs balance, presented as an elevated remodeling trend (i.e., relative \nimbalance favoring proteolysis) in lesions and interface contexts. While the literature is diverse in how it reports \nTIMP-related regulation—often describing relative expression ratios, inhibitory balance, or functional effects— \nthe aggregated directional view commonly points to remodeling programs that favor invasive capacity. In results \nterms, this reflects a repeated theme: endometriotic tiss ue tends to exhibit a microenvironment that does not \nsimply express individual proteases, but shows broader shifts in regulatory balance that collectively support \nECM remodeling and invasive behavior [11], [12]. The figure’s compartmental emphasis indicate s that these \nimbalances are most apparent where lesion–host interactions are concentrated.  \nIntegrin/adhesion signaling is shown with strong directionality in lesions and at the peritoneal interface. This is \nconsistent with the widely described role of adhesion molecules and integrin-mediated interactions in supporting \nstable attachment to mesoth elial surfaces and facilitating downstream invasion. Although specific integrin \nsubunits and adhesion molecules vary across studies, the repeated reporting of altered adhesion-related signaling \nis an important results-level feature because it links the earlier “adhesion” stage with the “invasion/remodeling” \nstage; stable adhesion provides the physical and biochemical anchoring necessary for ECM remodeling and \ntissue infiltration [4], [12]. The interface context is especially relevant here because many mecha nistic \nexperiments examining adhesion and invasion explicitly model mesothelial interaction, and these studies \ncommonly identify adhesion systems as functionally connected to invasive capacity.  \nThe ECM degradation capacity feature is displayed with one of the highest directional magnitudes in lesions and \na strong magnitude at the peritoneal interface. This element captures the fact that the literature includes not only \nmarker-based studies (e.g.,  MMP expression) but also functional assays that quantify degradation, invasion \nthrough matrix-like substrates, and migration capacity under defined conditions. The convergence of marker and \nfunction is a recurring results-level observation: studies often report that lesion-derived cells or stromal fractions \ndemonstrate enhanced invasive behavior relative to comparator tissues, consistent with a remodeling phenotype \nthat supports lesion persistence and spatial expansion [11], [12]. In Figure 5, the high trend magnitude for ECM \ndegradation capacity reflects this convergence-of-evidence pattern.  \nThe figure further includes epithelial –mesenchymal-like transition (EMT -like) markers, shown with a \nmoderateto-strong lesion -local signal. This reflects recurrent reporting that endometriosis progression is \nassociated with cellular programs that enhance plasticity, migration, and invasive characteristics. Not all studies \nuse identical EMT definitions or markers, and the degree of emphasis varies by lesion subtype and model system; \nhowever, a recurring theme in mechanistic accounts is that endometriotic cells can display features consistent \nwith enhanced migratory/invasive phenotypes. In results terms, Figure 5 repr esents this as a directional trend \nthat is stronger in lesions than in eutopic tissue, and that is detectable in interface contexts where invasion \nmechanisms are often interrogated experimentally [3], [4], [11], [12].  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 194 www.rsisinternational.org \n        \n   \nA notable cross -compartment observation in Figure 5 is that eutopic endometrium in affected individuals \nfrequently shows intermediate elevation across multiple features, though generally lower than lesions. This \npattern is repeatedly noted in literature di scussing eutopic tissue alterations in endometriosis, and it appears in \nmultiple mechanistic domains beyond invasion alone. In the context of ECM remodeling and invasion, the \nresultlevel implication is simply that eutopic tissue can exhibit measurable diff erences in remodeling -related \nmarkers relative to baseline physiology, even though the strongest signals tend to localize to the ectopic \ncompartment where invasion is actively occurring. The interpretive meaning of this —whether it reflects \npredisposition, systemic modulation, or contextual response—will be addressed in Discussion, not here [3], [4], \n[7], [22].  \nFinally, the peritoneal interface context in Figure 5 consistently occupies an intermediate -to-high position, \nreinforcing that invasion -related biology is not purely intrinsic to lesion tissue but is also shaped by the host \nboundary environmentwhere ectopi c cells interact with mesothelial surfaces and local immune/inflammatory \nmediators. This observation is compatible with integrative models in which invasion depends on both cellular \nprograms and environmental permissiveness, but again, these mechanistic in teractions are reserved for the \ninterpretive section [4], [11], [12].  \nFigure 6. Hormonal support landscape: local estrogenic activity and progesterone resistance.  \n  \nFigure 6 synthesizes the major endocrine-related findings repeatedly reported in the endometriosis literature into \nan integrated results -level architecture that links local estrogen biosynthesis, progesterone resistance, and \n\n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 195 www.rsisinternational.org \n        \n   \ndownstream lesion survival/growth programs, while explicitly representing the recurring observation of bi -\ndirectional reinforcement with inflammatory networks and stromal – immune–vascular crosstalk. The figure is \npresented as a structured summary of conver gent evidence rather than a claim of a single unified mechanism. \nAcross study types, endocrine alterations appear most consistently as (i) increased local estrogenic signaling \ncapacity in ectopic tissue environments and (ii) reduced responsiveness to proge sterone-associated regulatory \npathways, commonly referred to as progesterone resistance—together forming an endocrine context that aligns \nwith lesion persistence and expansion [2], [3], [4], [15], [22].  \nLocal estrogen biosynthesis and estrogen-dominant signaling (upper left module). The first module reflects the \nrepeated reporting that ectopic lesions and lesion -associated stromal compartments can demonstrate enhanced \nlocal estrogenic activity, including the presence of lesion -local steroidogenic processes described in many \nmechanistic accounts. While the specific molecular features used to support this vary across studies (e.g., enzyme \nexpression profiles, signaling readouts, pathway signatures), the resu lts-level pattern consistently frames \nestrogen as a dominant pro -survival/proliferative context in many lesion phenotypes. This module is included \nbecause it is repeatedly used as a mechanistic anchor for lesion persistence: local estrogenic signaling is \nfrequently reported as more prominent in ectopic tissue contexts than expected under baseline physiology, \nreinforcing the view that lesions can sustain hormonally favorable microenvironments [2], [3], [15].  \nProgesterone resistance and reduced anti-inflammatory tone (upper middle module).  \nThe second module summarizes the recurrent observation that endometriosis is associated with attenuated \nprogesterone responsiveness, frequently described as altered progesterone receptor (PR) signaling or a reduced \nprogesterone-mediated regulatory/anti -inflammatory effect. In results terms, this is typically expressed as a \npattern of diminished progesterone -linked gene expression programs, altered receptor signaling profiles, or \nreduced functional response in tissue and cellular models. The key synthesized result is that progesterone’s \nnormal regulatory role in endometrial physiology appears less effective in the endometriosis context, and this \nfinding is repeatedly invoked to explain persistent inflammatory and proliferative signaling within lesion \nenvironments [2], [3], [4], [15], [22]. Figure 6 represents progesterone resistance as positioned downstream of \nestrogen-dominant signaling and upstream of growth/survival programs, reflecting a common reporting structure \nwhere estrogenic dominance and progesterone attenuation are jointly observed in lesion biology.  \nLesion survival and growth programs (upper right module).  \nThe third module consolidates findings that lesions show signatures consistent with proliferative support, \nreduced apoptosis susceptibility, and metabolic adaptation compatible with survival in ectopic, often \ninflammatory and hypoxic, environments. Although different studies emphasize different downstream features, \nthe aggregated result-level observation is that endocrine shifts align with a tissue state supportive of sustained \nlesion viability. In the literature, this module is frequently presented as the functional output of combined \nendocrine and inflammatory pressures rather than as an isolated endocrine effect. Accordingly, Figure 6 depicts \nlesion survival/growth programs as the downstream node receiving inputs from progesterone resistance and, \nthrough crosstalk, from inflammatory and microenvironmental pathways [3], [4], [22].  \nInflammatory amplification (lower left module) and the endocrine–inflammatory feedback loop.  \nOne of the most consistent cross -domain findings in endometriosis research is the close linkage between \nendocrine signaling and inflammation, particularly through pathways commonly summarized as COX -2/PGE2 \naxis and broader cytokine networks. In results terms, studies frequently report elevated inflammatory mediators \nin lesions and peritoneal environments alongside endocrine dysregulation, and many mechanistic papers present \nreciprocal relationships where inflammatory mediators can influence steroidogenic ac tivity while estrogenic \nsignaling can amplify inflammatory pathways [3], [4], [15]. Figure 6 captures this in two directions:  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 196 www.rsisinternational.org \n        \n   \n● arrows from estrogenic signaling and progesterone resistance into inflammatory amplification, reflecting \nrepeated reporting that endocrine dysregulation coexists with sustained inflammatory signaling; and  \n● a return arrow from inflammatory amplification to local estrogen biosynthesis, reflecting the frequently \ndescribed feedback logic in which inflammatory mediators are linked —through diverse intermediate \nmechanisms across studies —to local steroidogenic signa ling and lesion -supportive hormonal \nmicroenvironments [3], [4], [15], [22].  \nThis feedback depiction is intentionally presented as a results -level synthesis of recurring reporting patterns, \nwithout asserting a single obligatory pathway across all lesion types and clinical phenotypes.  \nStromal–immune–vascular crosstalk (lower middle module) and propagation toward vascular/neural remodeling \n(lower right node).  \nFigure 6 also summarizes evidence indicating that endocrine and inflammatory signals are repeatedly discussed \nwithin a broader network of stromal –immune–vascular interactions, which includes angiogenic support and \nECM remodeling cues. This module is included because many studies do not treat hormonal signaling as isolated \nto endocrine receptor activity; rather, hormonal alterations are frequently described as acting within stromal and \nimmune microenvironments, shaping angiogenic mediator profiles and contributing to lesion maintenance. The \narrow from “Lesion survival & growth programs” down toward this crosstalk module reflects that lesion \npersistence is commonly associated with microenvironmental remodeling, while the arrow from crosstalk back \nupward to survival/growth indicates the repeated depiction of reinforcing loops: stromal and immune interactions \nsupport angiogenesis and structural remodeling, which in turn stabilizes lesion viability [3], [4], [10], [12], [22]. \nThe final small node (“Vascular & neural remodeling signals”) is placed as a downstream interface to align this \nendocrine-centric figure with the vascular/neuroangiogenic patterns summarized earlier (e.g., Figure 4), \nreflecting the broader results-level convergence that vascular remodeling is a recurring companion to endocrine– \ninflammatory reinforcement in progression models [10], [12], [21], [22].  \nFigure 7. Neuroangiogenesis and pain -associated signaling: consolidated directional evidence across \ncompartments.  \n  \n\n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 197 www.rsisinternational.org \n        \n   \nFigure 7 summarizes recurrent findings related to neuroangiogenesis and nociceptive signaling reported across \nthe included literature, displayed as directional trends (↑ increased, ↓ decreased, ↔ variable/mixed) across three \ncompartments: ectopic lesions, eutopic endometrium in affected individuals, and the peritoneal milieu/lesion \ninterface. The figure is presented to organize the evidence supporting a key result -level observation: beyond \nvascularization, endometriosis lesions and their immediate microenvi ronment are frequently described as \nbiologically active sites enriched for neurotrophic and neuropeptidergic signals, along with structural correlates \nsuch as increased nerve fiber indices. As in prior figures, the heatmap does not present raw participant data; it \nreflects aggregated directional reporting across studies with varied models and measurement strategies.  \nA dominant pattern in Figure 7 is the consistently higher directional signal for NGF-related (nerve growth \nfactor) features in ectopic lesions, with intermediate-to-elevated trends at the peritoneal interface, and lower \nmagnitudes in eutopic tissue. This distribution is consistent with repeated reports that lesion compartments \ndemonstrate stronger neurotrophic signaling than eutopic tissue, and that neurotrophic factors are frequently \ndetectable in lesion-adjacent environments. NGF is commonly highlighted in mechanistic discussions because it \nis a canonical driver of neuronal growth and sensitization pathways in peripheral tissues, and its repeated \nelevation in lesion contexts is a recurrent finding in neurobiology-oriented endometriosis studies and high-level \nsyntheses [21], [22]. The compartmental pattern shown here reinforces the view that neurotrophic signaling is \nconcentrated where lesion–host interactions occur.  \nA similar compartmental shape is visible for BDNF-related signals (brain-derived neurotrophic factor), which \nshow increased directionality in lesions and interface contexts. While BDNF is not always emphasized to the \nsame degree as NGF in every study subset, it appears repeatedly in literature examining neural remodelin g and \npain-associated molecular signals. The trend profile —lesion-high, interface -intermediate, eutopic -lower— \nsupports the result -level conclusion that neurotrophic signaling is more charact eristic of ectopic lesion \nmicroenvironments than of eutopic tissue alone [21], [22].  \nThe figure also includes neuropeptidergic mediators and nociception -linked systems —Substance P , \nCGRPrelated signals , and TRPV1/neuronal sensitization markers —which show increased directionality \nprimarily in lesions and interface contexts, with comparatively smaller or more variable trends in eutopic tissue. \nThis pattern mirrors how the literature often distinguishes between (i) lesion-local biology where neurovascular \nand inflammatory interactions are concentrated and (ii) eutopic endometrium where some alt erations may exist \nbut are typically less pronounced for neuropeptide -rich signatures. In results terms, the repeated reporting of \nneuropeptide-associated signals in lesion compartments is frequently presented as a biological correlate of lesion \ninnervation and local neural activity, without requiring immediate interpretation of symptom consequences \nwithin the Results section [21], [22].  \nA particularly informative feature in Figure 7 is nerve fiber density (NFD proxy) , shown with a strong \nlesionlocal directional increase and intermediate elevation in the peritoneal interface context. Many studies \nevaluate nerve fibers using immunohistochemical approaches (with variable markers and counting strategies), \nand while methods differ, a recurring result-level observation is that lesions—especially in specific phenotypes \nand anatomical contexts —are associated with increased neural elements relative  to comparator tissues. The \nfigure summarizes this as a high -magnitude lesion signal with detectable interface elevation, reflecting that \nneural structural correlates are frequently localized to the lesion microenvironment rather than distributed \nuniformly across all endometrial compartments [21], [22].  \nFinally, Figure 7 includes a synthesis feature labeled neurovascular coupling (angiogenic–neural crosstalk), \nshown with a high lesion and interface trend. This element is included to reflect that neuroangiogenesis is often \ndiscussed as an integrated process: vascular remodeling and neural remodeling appear together within lesion \nbiology frameworks. The conceptual basis for including neurovascular coupling as a results feature is that many \nmechanistic models describe shared mediators and shared microenvironm ental drivers —particularly \ninflammatory mediators and growth factors —that plausibly support parallel angiogenic and neurotrophic \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 198 www.rsisinternational.org \n        \n   \nprocesses in the lesion niche. Figure 7 therefore summarizes repeated reporting that angiogenesis -related and \nneurotrophic/nociceptive signals tend to co -occur in lesion -associated environments, even though interpretive \nclaims about causality remain reserved for Discussion [10], [12], [21], [22].  \nA cross-compartment observation in this figure is that eutopic endometrium in affected individuals  often \nshows lower or more variable directional patterns for neuroangiogenesis-associated features than lesions, with \nTRPV1-related sensitization displayed as comparatively mixed. This heterogeneity is consistent with how the \nliterature often frames eutopic tissue findings: some signals can be altered, but the most robust \nneuroangiogenesis-related signatures tend to cluster around lesion microenvir onments and a djacent interface \ncompartments. In results terms, Figure 7 documents this compartmental stratification rather than attempting to \nexplain it [3], [4], [22].  \nFigure 8. Integrated mechanistic model summarizing convergence points and reinforcing loops across \nimplantation and lesion expansion.  \n  \n\n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 199 www.rsisinternational.org \n        \n   \nFigure 8 integrates the consolidated results from the preceding figures into a single systems -style model that \ncaptures how recurrent mechanistic domains co-occur and align across the endometriosis progression literature. \nThe model is organized into (i) a top row representing the core progression sequence—from adhesion/retention \nto invasion/ECM remodeling, then angiogenesis/neuroangiogenesis, and finally lesion maintenance and \nremodeling—and (ii) a lower row representing three repeatedly reported supportive  modules that reinforce \nprogression: chronic inflammation/immune tolerance, endocrine support (local estrogenic activity and \nprogesterone resistance), and microenvironmental reinforcement (oxidative stress, hypoxia, stromal cues). The \narrows depict directi onal relationships that are commonly described across mechanistic and translational \nevidence; however, as in all results summaries here, the figure is intended to reflect recurrent reporting patterns \nand co-alignment, not to impose a single causal chain on a heterogeneous disease [3], [4], [22].  \n1) Core progression sequence: adhesion → invasion/ECM remodeling → vascular/neural support → \nmaintenance  \nThe top row reflects a consistent narrative that emerges across study designs when the literature is organized by \nimplantation and expansion stages. First, adhesion and retention at mesothelial surfaces appears as a prerequisite \nstep for implantation, freq uently modeled in vitro and supported by translational findings describing altered \nadhesion-related signaling in lesion contexts [4], [12]. Second, evidence repeatedly converges on ECM \nremodeling and invasion as the structural transition that allows ectopi c tissue to establish a stable niche — \ncommonly characterized through MMP-related signatures and remodeling capacity (as summarized in Figure 5) \n[11], [12]. Third, the model places angiogenesis and neuroangiogenesis after invasion because lesion persistence \nrequires metabolic and trophic support; vascular remodeling is repeatedly reported as a sustaining feature of \nlesion growth, and neural remodeling is increasingly described as co-occurring within lesion microenvironments \n(as summarized in Figures 4 and 7) [10], [12], [21], [22]. Finally, the “maintenance & remodeling” node captures \nthe broader result -level observation that established lesions often show patterns consistent with long -term \nsurvival, ongoing remodeling programs, and variable trajectories that  include chronic remodeling and, in some \nphenotypes, fibrotic change [3], [7], [22].  \n2) Chronic inflammation and immune tolerance as a cross-stage reinforcing module  \nA major feature of Figure 8 is the placement of chronic inflammation and immune tolerance as a supportive \nmodule feeding into early and mid -progression stages. This reflects repeated evidence that lesion -associated \nenvironments demonstrate persistent inflammatory mediator profiles, macrophage-centered immune signatures, \nand reduced clearance capacity—features that align with the concept of a permissive immune microenvironment \nfor lesion establishment (as summarized in Figure 3) [8], [9], [14]. In the integr ated model, arrows extend from \nthis module to (a) adhesion/retentionand (b) invasion/ECM remodeling, reflecting that inflammatory contexts \nand immune -cell shifts are frequently reported alongside enhanced adhesion and remodeling behavior in \nmechanistic frameworks [4], [11], [12]. The figure also includes immune features such as “reduced clearance” \nwithin the module, aligning with repeated reporting of altered cytotoxic surveillance and immune tolerance \nsignatures in endometriosis -associated immune milieus [ 8], [9], [14]. Importantly, this depiction is \nresultsaligned: it communicates that immune–inflammatory alterations are not restricted to advanced lesions but \nare repeatedly positioned as foundational context across stages [3], [4], [22].  \n3) Endocrine support: local estrogenic activity and progesterone resistance  \nThe second supportive module summarizes endocrine-related findings (expanded in Figure 6), emphasizing local \nestrogenic activity and progesterone resistance as recurring features across lesion and, in some studies, eutopic \ntissue in affected individuals [2 ], [3], [15]. In Figure 8, endocrine support feeds directly into \nangiogenesis/neuroangiogenesis, reflecting that hormonal signaling is frequently discussed as intertwined with \nvascular remodeling and lesion growth programs. Although different studies empha size different intermediates \n(e.g., inflammatory amplification, stromal signaling), the integrated model captures a consistent result -level \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 200 www.rsisinternational.org \n        \n   \nalignment: endocrine dysregulation co-occurs with pro-angiogenic and persistence-supporting programs [3], [4], \n[10], [12], [15], [22]. The module is also placed centrally to reflect its repeated role in bridging inflammatory \nstates and growth-supportive microenvironments, consistent with how many high -level syntheses frame lesion \npersistence [3], [22].  \n4) Microenvironmental reinforcement: oxidative stress, hypoxia, stromal cues  \nThe third supportive module captures microenvironmental conditions frequently reported as relevant to lesion \nsurvival and stabilization, including oxidative stress, hypoxia-associated signaling, and stromal cues that support \nremodeling. These conditions ar e commonly referenced as pressures that shape early lesion survival and later \nstabilization, particularly in the context of sustained inflammation and vascular remodeling. In Figure 8, the \nmodule feeds into lesion maintenance/remodeling, reflecting the rep eated reporting that chronic \nmicroenvironmental stressors and stromal interactions align with persistence and remodeling trajectories. While \nexact markers differ by model and tissue compartment, the recurrent pattern is that microenvironmental \nconditions are described as persistent features of lesion niches, compatible with survival under ectopic conditions \nand long-term remodeling [3], [4], [22].  \n5) Convergence points as recurring “junctions” in the literature  \nA distinctive aspect of Figure 8 is the explicit representation of convergence points as a separate node. This node \nsummarizes junctions where multiple mechanistic domains repeatedly intersect:  \n● ECM remodeling + vascular growth: Lesion establishment is frequently described as requiring both tissue \ninvasion and subsequent vascular support. The repeated co -occurrence of remodeling mediators (e.g., \nMMP-associated signatures) with angiogenic mediators and vascular indices motivates their depiction as \na coupled convergence point, consistent with Figures 4 and 5 [10]–[12], [29].  \n● Immune–endocrine feedback: Many studies and reviews describe reciprocal reinforcement between \ninflammatory networks and steroid-related signaling, particularly in relation to COX -2/PGE2 pathways \nand local steroidogenic environments; Figure 8 captures this as a bidirectional link between inflammation \nand endocrine modules [3], [4], [15], [22].  \n● Neurovascular coupling: The co-alignment of angiogenesis with neurotrophic and nociceptive signaling \npatterns in lesion compartments (Figures 4 and 7) supports representing neurovascular coupling as a \nrecurring junction rather than an isolated pathway [10], [12], [21], [22].  \n● Remodeling/fibrosis trajectories: Fibrosis and remodeling appear as outcome trajectories particularly \nemphasized in some phenotypes and lesion locations; even when less densely represented in study counts, \nremodeling emerges repeatedly as a long -term structural context for persistence and recurrence -related \nframeworks, supporting its inclusion as a convergence feature [3], [7], [22].  \nBy placing these junctions in a dedicated node and linking them to the three supportive modules, Figure 8 \nexpresses a key result -level observation: across heterogeneous models, the literature often converges not on \nsingle markers but on interacting functio nal themes —remodeling, vascularization, immune \ntolerance/inflammation, endocrine dysregulation, and neurovascular remodeling —that recur together in \nlesionassociated compartments [3], [4], [22].  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 201 www.rsisinternational.org \n        \n   \nDISCUSSION  \nThe present review integrates mechanistic evidence to clarify how endometriosis progresses from initial \nimplantation to sustained expansion and long-term lesion maintenance. Rather than supporting a unidimensional \netiological explanation, the synthesized findings reinforce the concept of endometriosis as a dynamic, multistep, \nand self-reinforcing disease process, in which ectopic endometrial tissue survives, adapts, and expands through \nthe convergence of inflammatory, immune, endocrine, vascular, and neural  mechanisms. This integrative view \nis consistent with contemporary frameworks that emphasize disease progression rather than static lesion presence \n[3], [4], [22].  \nImplantation as a selective and permissive process  \nThe results summarized in Figures 1, 2, and 5 support the interpretation that implantation of ectopic endometrial \ntissue is a selective biological event, not merely a consequence of tissue displacement. While retrograde \nmenstruation remains a foundational explanatory model, its inability to account for disease selectivity has been \nwidely acknowledged [19], [3]. The convergence of adhesion, invasion, and ECM remodeling signatures in \nectopic lesions indicates that successful implantation requires both intrinsic cellular adaptability and a permissive \nhost environment [4], [11], [12].  \nThe consistent elevation of MMP-related remodeling capacity and adhesion-related signaling supports the notion \nthat endometriotic cells actively modify their microenvironment to secure attachment and invasion. This aligns \nwith models in which endometriosis  progression parallels key features of tissue invasion observed in other \nchronic inflammatory and remodeling -associated conditions, without implying neoplastic behavior [3], [12]. \nImportantly, the presence of intermediate remodeling signals in eutopic tissue from affected individuals suggests \nthat implantation competence may not be restricted to ectopic sites alone, raising questions about systemic or \nendometrium-wide susceptibility [4], [7].  \nImmune dysregulation and chronic inflammation as foundational drivers  \nOne of the most robust findings across the reviewed literature is the central role of immune dysregulation and \nchronic inflammation. As illustrated in Figures 3 and 8, inflammatory mediators, macrophage-centered immune \nsignatures, and reduced cytotoxic sur veillance repeatedly co -occur across lesion and peritoneal compartments \n[8], [9], [14]. Rather than reflecting an exaggerated immune response alone, these patterns suggest a \nreprogrammed immune environment that tolerates ectopic tissue while sustaining inflammatory signaling.  \nThe paradoxical coexistence of heightened inflammatory cytokines and reduced NK cell cytotoxicity supports \nthe hypothesis that endometriosis involves immune tolerance rather than immune hyperactivity [8], [9]. This \ntolerance likely facilitates lesion persistence by limiting effective clearance of ectopic cells, while inflammation \nsimultaneously promotes angiogenesis, ECM remodeling, and nociceptive signaling [3], [4], [22]. Such an \nimmune profile may explain why lesions can persist over time despite an ostensibly activated inflammatory state. \nEndocrine dysregulation as a sustaining force  \nThe discussion of endocrine mechanisms, synthesized in Figures 6 and 8, highlights local estrogenic activity and \nprogesterone resistance as central reinforcing elements of disease progression. The literature consistently \ndescribes ectopic lesions as existing within an estrogen-dominant signaling environment, often accompanied by \nreduced responsiveness to progesterone-mediated regulatory pathways [2], [3], [15]. This endocrine imbalance \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 202 www.rsisinternational.org \n        \n   \ncontributes to sustained inflammatory activation, cellular proliferation, and resistance to apoptosis—features that \nalign with long-term lesion maintenance [4], [22].  \nImportantly, the reviewed evidence supports a bidirectional relationship between endocrine and inflammatory \npathways. Inflammatory mediators are frequently reported to modulate local steroidogenic signaling, while \nestrogenic activity amplifies inflammatory  cascades, creating a self -reinforcing loop [3], [4], [15]. This \ninteraction challenges traditional views that treat hormonal dysregulation as an isolated upstream factor and \ninstead positions endocrine signaling as an integral component of a broader infla mmatory–immune–stromal \nnetwork.  \nAngiogenesis and neuroangiogenesis as hallmarks of lesion expansion  \nVascular and neural remodeling emerge as critical features of lesion expansion rather than mere consequences of \ntissue growth. As demonstrated in Figures 4 and 7, angiogenesis-related signals and neurotrophic mediators are \nconsistently elevated in ectopic lesions and lesion -adjacent environments [10], [12], [21], [22]. The \ncolocalization of vascular and neural features supports the concept of neuroangiogenesis, in which shared \nmediators and microenvironmental cues promote parallel development of blood vessels and nerve fibers.  \nThis convergence has important implications for understanding lesion persistence and symptomatology. \nIncreased nerve fiber density and neuropeptidergic signaling within lesions provide a biological substrate for \npain generation, while vascular remodeling e nsures metabolic support for lesion survival [21], [22]. The \nconsistent alignment of angiogenic and neurotrophic pathways reinforces the view that endometriosis \nprogression involves coordinated tissue remodeling rather than isolated pathway activation [10], [12].  \nMicroenvironmental reinforcement and remodeling trajectories  \nThe integrated model (Figure 8) emphasizes that endometriosis lesions exist within hostile yet supportive \nmicroenvironments, characterized by oxidative stress, hypoxia, and stromal interactions. These conditions, \nfrequently reported across mechanistic stud ies, likely exert selective pressure that favors adaptable cell \npopulations capable of long-term survival [3], [4], [22]. Over time, such environments may promote remodeling \ntrajectories that include fibrosis, architectural distortion, and reduced tissue p lasticity, particularly in deep or \nlong-standing lesions [7], [22].  \nAlthough fibrosis is less uniformly represented across studies, its recurrent mention in relation to chronic disease \nstages supports its inclusion as a potential outcome of sustained remodeling. The heterogeneity observed across \nlesion types and anatomical locations underscores the need to interpret fibrosis as a context-dependent trajectory, \nrather than a universal endpoint [3], [7].  \nIntegrative implications and future directions  \nCollectively, the findings synthesized in this review support a systems -level interpretation of endometriosis \nprogression, in which implantation, immune tolerance, endocrine dysregulation, angiogenesis, \nneuroangiogenesis, and microenvironmental stress form  interdependent networks. No single mechanism \nsufficiently explains disease persistence; instead, progression appears to depend on reinforcing feedback loops \nthat stabilize ectopic tissue over time [3], [4], [22].  \nThis integrative perspective has important implications for future research. First, it highlights the limitations of \nreductionist approaches that focus on isolated pathways without accounting for cross -domain interactions. \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 203 www.rsisinternational.org \n        \n   \nSecond, it supports the need for longitudinal and multi -compartmental studies capable of capturing dynamic \nchanges across disease stages. Finally, it underscores the value of incorporating diverse research contributions— \nincluding those from Latin American  scientific communities—into global syntheses of endometriosis biology, \nensuring that disease models reflect broad biological and population-level variability.  \nCONCLUSION \nThis review consolidates current mechanistic evidence to clarify how endometriosis progresses from initial \nectopic implantation to sustained lesion expansion and long -term persistence. The findings support the study \nobjective of describing progression as a multistep and self-reinforcing biological process, rather than as a static \ncondition or the consequence of a single causal mechanism. Across the analyzed literature, lesion establishment \nemerges as a selective event that requires coordinated processes of adhesion, invasion, and extracellular matrix \nremodeling, supported by permissive immune and microenvironmental conditions [3], [4], [11], [12].  \nA central conclusion of this review is that chronic inflammation and immune dysregulation  represent \nfoundational elements of disease progression. The recurrent coexistence of elevated inflammatory mediators \nwith impaired cytotoxic immune surveillance suggests that endometriosis is characterized by immune tolerance \nrather than simple immune activation. This altered immune state facilitates lesion survival and expansion while \nsimultaneously promoting angiogenic, remodeling, and nociceptive signaling [8], [9], [14], [22]. These findings \nalign directly with the objective of explaining how ectopic tissue evades clearance and persists over time.  \nThe evidence further demonstrates that endocrine dysregulation , particularly local estrogenic activity and \nprogesterone resistance, functions as a critical sustaining force in lesion biology. Rather than acting \nindependently, hormonal alterations are consistently reported to interact with inflammatory and stromal \npathways, forming reinforcing feedback loops that support proliferation, resistance to apoptosis, and chronic \ninflammatory activation [2], [3], [15]. This integrated endocrine –inflammatory axis pro vides a coherent \nexplanation for lesion persistence and recurrence, fulfilling the review’s aim of linking molecular mechanisms \nwith progression dynamics.  \nAnother major conclusion is the central role of angiogenesis and neuroangiogenesis  in lesion expansion. \nVascular remodeling ensures metabolic support for ectopic tissue, while neural remodeling and neurotrophic \nsignaling are repeatedly detected within lesion environments. The convergence of angiogenic and neurotrophic \npathways supports the concept of coordinated tissue remodeling rather than isolated pathway activation, \nreinforcing the progressive nature of the disease [10], [12], [21], [22].  \nFrom a theoretical perspective, these findings contribute to the field by strengthening systems -based models of \nendometriosis that emphasize interaction among immune, endocrine, vascular, neural, and stromal domains. \nFrom a practical standpoint, the result s underscore the limitations of approaches that target single pathways in \nisolation and highlight the need for integrative strategies in both research and clinical contexts.  \nThis review is subject to limitations inherent to narrative integrative analyses, including heterogeneity in study \ndesigns, lesion phenotypes, and experimental models, which restrict direct quantitative comparison. \nAdditionally, fibrosis and long -term remo deling trajectories remain underrepresented in some domains, \nindicating areas where further focused research is warranted.  \nFuture investigations should prioritize longitudinal, multi -compartmental studies capable of capturing dynamic \ninteractions across disease stages, as well as collaborative international research that reflects population diversity \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 204 www.rsisinternational.org \n        \n   \nand regional variability. Such approaches are essential to refine mechanistic models of progression and to \ntranslate biological insights into more effective strategies for disease management [3], [4], [22].  \nREFERENCES  \n1. L. C. Giudice and L. C. Kao, “Endometriosis,” The Lancet, vol. 364, no. 9447, pp. 1789–1799, 2004.  \n2. S. Bulun, “Endometriosis,” The New England Journal of Medicine, vol. 360, no. 3, pp. 268–279, 2009.  \n3. P. Vercellini, P. Vigano, E. Somigliana, and L. Fedele, “Endometriosis: pathogenesis and treatment,” Nature \nReviews Endocrinology, vol. 10, no. 5, pp. 261–275, 2014.  \n4. R. O. Burney and L. C. Giudice, “Pathogenesis and pathophysiology of endometriosis,” Fertility and \nSterility, vol. 98, no. 3, pp. 511–519, 2012.  \n5. P. A. Rogers et al., “Defining future directions for endometriosis research,” Human Reproduction Update, \nvol. 15, no. 5, pp. 481–500, 2009.  \n6. A. R. McKinnon, K. Kocbek, T. N. Nirgianakis, M. Bersinger, and M. D. Mueller, “Kinase signalling \npathways in endometriosis: potential targets for non-hormonal therapeutics,” Human Reproduction Update, \nvol. 22, no. 3, pp. 382–403, 2016.  \n7. P. Vigano, E. Somigliana, P. Panina-Bordignon, A. Busacca, and M. Candiani, “Principles of phenomics in \nendometriosis,” Human Reproduction Update, vol. 18, no. 3, pp. 248–259, 2012.  \n8. [8] K. M. May et al., “Inflammation and angiogenesis in endometriosis,” Reproductive Sciences, vol. 18, \nno. 8, pp. 673–682, 2011.  \n9. M. A. Lebovic, D. R. Mueller, and R. N. Taylor, “Immunobiology of endometriosis,” Fertility and Sterility, \nvol. 75, no. 1, pp. 1–10, 2001.  \n10. R. N. Taylor, M. A. Lebovic, and D. L. Mueller, “Angiogenic factors in endometriosis,” Annals of the New \nYork Academy of Sciences, vol. 955, pp. 89–100, 2002.  \n11. S. A. Defrère et al., “Matrix metalloproteinases and endometriosis,” Human Reproduction Update, vol. 14, \nno. 6, pp. 561–575, 2008.  \n12. A. L. Laschke and M. D. Menger, “Basic mechanisms of vascularization in endometriosis,” \nMicrocirculation, vol. 19, no. 1, pp. 1–10, 2012.  \n13. H. Harada, T. Taniguchi, and N. Yoshida, “Mechanisms of chronic inflammation in endometriosis,” \nFrontiers in Bioscience, vol. 16, pp. 447–463, 2011.  \n14. K. Ahn et al., “Role of immune cells in the development of endometriosis,” International Journal of \nMolecular Sciences, vol. 16, no. 8, pp. 18546–18565, 2015.  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 205 www.rsisinternational.org \n        \n   \n15. P. Vercellini et al., “Endometriosis: current therapies and new pharmacological developments,” Drugs, vol. \n69, no. 6, pp. 649–675, 2009.  \n16. N. Burney and R. N. Taylor, “Endometriosis and implantation,” Seminars in Reproductive Medicine, vol. \n31, no. 2, pp. 93–101, 2013.  \n17. C. M. Kyama et al., “Potential involvement of the immune system in the development of endometriosis,” \nReproductive Biology and Endocrinology, vol. 1, no. 1, pp. 1–10, 2003.  \n18. L. Bruner -Tran and K. Osteen, “Developmental exposure to TCDD reduces fertility and enhances \ninflammation in endometriosis,” Reproductive Toxicology, vol. 28, no. 2, pp. 226–234, 2009.  \n19. M. Sampson, “Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue,” \nAmerican Journal of Obstetrics and Gynecology, vol. 14, pp. 422–469, 1927.  \n20. P. Brosens et al., “Endometriosis is a bleeding disorder,” Human Reproduction, vol. 24, no. 8, pp. 2002 –\n2007, 2009.  \n21. T. N. Nirgianakis et al., “Inflammation and nerve growth in endometriosis,” Human Reproduction Update, \nvol. 22, no. 6, pp. 799–815, 2016.  \n22. M. Zondervan, K. Becker, and S. Missmer, “Endometriosis,” The New England Journal of Medicine, vol. \n382, no. 13, pp. 1244–1256, 2020.  \n23. A. L. Herington et al., “Macrophages in endometriosis,” Journal of Endometriosis and Pelvic Pain \nDisorders, vol. 7, no. 2, pp. 59–68, 2015.  \n24. J. A. Nap et al., “Endometriosis: a disease of theories,” Human Reproduction Update, vol. 10, no. 1, pp. \n87–99, 2004.  \n25. M. Klemmt and C. Starzinski -Powitz, “Molecular and cellular pathogenesis of endometriosis,” Current \nWomen’s Health Reviews, vol. 14, no. 2, pp. 106–116, 2018.  \n26. E. Burney, “Clinical aspects of endometriosis,” Obstetrics and Gynecology Clinics of North America, vol. \n44, no. 3, pp. 419–431, 2017.  \n27. S. Laganà et al., “Endometriosis: molecular pathways involved in pathogenesis,” International Journal of \nMolecular Sciences, vol. 20, no. 22, p. 5612, 2019.  \n28. P. Vigano et al., “Inflammation and endometriosis,” Journal of Endometriosis, vol. 1, no. 1, pp. 9– 16, 2009.  \n29. M. D. Mueller et al., “Endometriosis and angiogenesis,” Human Reproduction Update, vol. 6, no. 1, pp. \n19–26, 2000.  \n\nINTERNATIONAL JOURNAL OF RESEARCH AND SCIENTIFIC INNOV ATION (IJRSI) \nISSN No. 2321-2705 | DOI: 10.51244/IJRSI |V olume XIII Issue II February 2026 \nPage 206 www.rsisinternational.org \n        \n   \n30. S. Guo, “Recurrence of endometriosis and its control,” Human Reproduction Update, vol. 15, no. 4, pp. \n441–461, 2009.","source_license":"CC0","license_restricted":false}